AmerisourceBergen Corporation, ABC is in the exchange NYSE and its industry is Drugs Wholesale in the sector of Services. Based in USA, AmerisourceBergen Corporation, ABC has a market cap of 17121.38. Since its IPO date on the 04/04/1995, AmerisourceBergen Corporation, ABC performance year to date is -22.05%. Today AmerisourceBergen Corporation, ABC has gained 0.51%, with a current price of 80.57.
Ownership of the company is 0.10% for insider ownership while institutional ownership is 82.40%. The management of the company have seen the company have a payout ratio of 17.50%. Return of assets are at 5.10%, with return on investment at -0.50%.
In terms of debt levels and profit levels, AmerisourceBergen Corporation, ABC is seeing a long-term debt/equity of 1.99. While Total debt/equity is 2.05. With a profit margin of 1.10%, this is combined with a gross margin of 2.80%, and operating margin of 1.10%. AmerisourceBergen Corporation ability to meet debt levels, with a current ratio of 0.9, while the quick ratio is 0.5.
For the last year AmerisourceBergen Corporation, ABC has seen a EPS growth of -151.30%. A performance for the year of -24.05%. The 52-week high is -29.16%, and the 52-week low is 10.06%. The average volume for AmerisourceBergen Corporation, ABC is 975608.
With a target price of 85.25, can AmerisourceBergen Corporation, ABC reach this target? Looking at the value indicators of AmerisourceBergen Corporation, ABC. AmerisourceBergen Corporation has a P/E of 11.88 and a forward P/E of 13.72. Perhaps the more useful indicator than P/E, is PEG which has a value of 1.05. AmerisourceBergen Corporation also has a P/S and a P/B of 0.12 and 7.61 respectively. For P/cash, AmerisourceBergen Corporation has a value of 6.78, while it is 5.13 for P/free cash flow.
At the current price of 80.57, AmerisourceBergen Corporation has a dividend yield of 1.70%. We see a return on equity of 106.20%.
Looking more long-term AmerisourceBergen Corporation, is projected to get an EPS growth for the next five years of 11.30%. In the short-term an EPS growth of 5.91% in the next year is forecasted. This is after a EPS growth of -151.30% for this year and for the last five years a -17.90% growth has been seen.